83 results
Page 2 of 5
8-K
EX-99.1
kgf4uy cccu
10 May 22
Zai Lab Announces First Quarter 2022
4:10pm
8-K
EX-99.1
0t0k69tqvf6 o6vdk
21 Apr 22
Zai Lab Announces Engagement of KPMG LLP, a U.S. Auditor, as the Company’s Independent Registered Public Accounting Firm
7:34am
DEFA14A
y1piwob
23 Mar 22
Additional proxy soliciting materials
7:38am
8-K
EX-99.1
jv5v 2yg7q5
15 Mar 22
Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer
8:31am
8-K
EX-99.1
8wcq y2baw
1 Mar 22
Results of Operations and Financial Condition
4:17pm
8-K
EX-99.1
0cna9st5uv4j
6 Jan 22
Zai Lab Announces NDA Acceptance of
7:44am
8-K
EX-99.1
j07 ha4h0mt
22 Dec 21
Zai Lab announces promotion of Harald Reinhart M.D. to President and Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases
4:14pm
8-K
EX-99.1
eq2q udswgv
16 Dec 21
China NMPA Approves NUZYRA® as a Category 1
7:43am
8-K
EX-99.1
o9ppj
3 Dec 21
Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List for First-Line Ovarian Cancer
7:45am
8-K
EX-99.1
gmmic
22 Nov 21
Zai Lab Appoints Richard Gaynor, MD, to its Board of Directors
7:40am
8-K
EX-99.1
w9h4 shhvujp1ma
9 Nov 21
Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License
4:26pm
8-K
EX-99.2
77ijkq fmvnf35
9 Nov 21
Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License
4:26pm
8-K
EX-99.3
z8wswb i30yon6
9 Nov 21
Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License
4:26pm
8-K
EX-99.1
8zt yfqg9fwqy37j
20 Oct 21
ZL-1102, Zai Lab’s Internally Developed Novel Human
4:06pm
8-K
EX-99.1
1kxo1u
19 Oct 21
Zai Lab and Entasis Therapeutics Announce Positive
9:21am